Loading company…
Proteolix develops therapeutics targeting protein degradation pathways for cancer and autoimmune diseases.
Proteolix discovers and develops therapeutics that target protein degradation pathways for cancer and autoimmune diseases.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in